pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 30·1 min read
save

Study finds OpenAI large language model outperforms doctors in diagnostic and clinical reasoning tasks

Apr 30, 2026·read at STAT ↗Positive readoutPositive

Researchers from Boston published a paper in Science describing a series of experiments that tested an OpenAI large language model on real‑world diagnostic and clinical reasoning cases drawn from an emergency department.

The model performed better than practicing physicians on case‑based evaluations, achieving higher accuracy in identifying conditions and suggesting appropriate next steps.

The authors highlight the need for rigorous clinical trials before such tools are deployed widely, warning that marketing hype could outpace solid evidence.

They see the results as a step toward integrating AI into clinical decision support, but stress that safety, validation, and regulatory oversight remain essential.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: As artificial intelligence shows off diagnostic chops, scientists reckon with the way forward”

read at STAT ↗
524 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
SERVIER
drugs
Obesity
topics
Obesity2

related stories

  • Jun 2STAT+: Radiopharmaceutical shows promise in post-Pluvicto settingSTAT
  • Jun 1STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concernsSTAT
  • May 30STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur saysSTAT
  • May 14Makary’s departure and Cassidy’s tenuous Senate seatSTAT
  • May 7Seaport’s IPO adventure, obesity pill battles, and Makary’s troublesSTAT